title: Reply to "The challenge of cross-trial comparison using limited data" Haematologica. 2014;99(8):e000.
authors.affiliation: John Theurer Cancer Center, Hackensack, NJ, USA dsiegel@hackensackumc.org.
authors.forename: David S
authors.initials: DS
authors.lastname: Siegel
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects*; D061988:Proteasome Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D009842:Oligopeptides; D061988:Proteasome Inhibitors
keywords: challenge; cross-trial; data
references.citation: Leukemia. 2013 Aug;27(8):1707-14
references.pmid: 23364621
references.citation: Blood. 2012 Oct 4;120(14):2817-25
references.pmid: 22833546
references.citation: Br J Haematol. 2012 Sep;158(6):739-48
references.pmid: 22845873
references.citation: Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):310-8
references.pmid: 23040437
references.citation: Blood. 2012 Jun 14;119(24):5661-70
references.pmid: 22555973
references.citation: Haematologica. 2013 Nov;98(11):1753-61
references.pmid: 23935022
references.citation: Haematologica. 2014 Aug;99(8):e145-6
references.pmid: 25082787